메뉴 건너뛰기




Volumn 42, Issue 1, 2014, Pages 57-61

A meta-analysis on the association between high-density lipoprotein particle subfractions and cardiovascular disease events

Author keywords

Cardiovascular diseases; Lipoproteins HDL; Meta analysis

Indexed keywords

CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; HUMANS; RISK FACTORS;

EID: 84893855816     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2014.01.013     Document Type: Article
Times cited : (4)

References (20)
  • 1
    • 0017384270 scopus 로고
    • High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
    • Gordon T, Castelli W P, Hjortland M C, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study [J]. Am J Med, 1977, 62:707-714.
    • (1977) Am J Med , vol.62 , pp. 707-714
    • Gordon, T.1    Castelli, W.P.2    Hjortland, M.C.3
  • 2
    • 0024501678 scopus 로고
    • High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies
    • Gordon D J, Probstfield J L, Garrison R J, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies[J]. Circulation, 1989, 79: 8-15.
    • (1989) Circulation , vol.79 , pp. 8-15
    • Gordon, D.J.1    Probstfield, J.L.2    Garrison, R.J.3
  • 3
    • 0025978913 scopus 로고
    • Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease
    • Romm P A, Green C E, Reagan K, et al. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease [J]. Am J Cardiol, 1991, 67: 479-483.
    • (1991) Am J Cardiol , vol.67 , pp. 479-483
    • Romm, P.A.1    Green, C.E.2    Reagan, K.3
  • 4
    • 34047106220 scopus 로고    scopus 로고
    • Effect of torcetrapib on the progression of coronary atherosclerosis
    • Nissen S E, Tardif J C, Nicholls S J, et al. Effect of torcetrapib on the progression of coronary atherosclerosis [J]. N Engl J Med, 2007, 356: 1304-1316.
    • (2007) N Engl J Med , vol.356 , pp. 1304-1316
    • Nissen, S.E.1    Tardif, J.C.2    Nicholls, S.J.3
  • 5
    • 77952357848 scopus 로고    scopus 로고
    • High-density lipoprotein heterogeneity and function in reverse cholesterol transport
    • Rothblat G H, Phillips M C. High-density lipoprotein heterogeneity and function in reverse cholesterol transport [J]. Curr Opin Lipidol, 2010, 21:229-238.
    • (2010) Curr Opin Lipidol , vol.21 , pp. 229-238
    • Rothblat, G.H.1    Phillips, M.C.2
  • 6
    • 79952222810 scopus 로고    scopus 로고
    • HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events
    • Rosenson R S, Brewer H B Jr, Chapman M J, et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events [J]. Clin Chem, 2011, 57: 392-410.
    • (2011) Clin Chem , vol.57 , pp. 392-410
    • Rosenson, R.S.1    Brewer Jr., H.B.2    Chapman, M.J.3
  • 7
    • 84870291668 scopus 로고    scopus 로고
    • High-density lipoprotein subclasses and their relationship to cardiovascular disease
    • Superko H R, Pendyala L, Williams P T, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease[J]. J Clin Lipidol, 2012, 6: 496-523.
    • (2012) J Clin Lipidol , vol.6 , pp. 496-523
    • Superko, H.R.1    Pendyala, L.2    Williams, P.T.3
  • 8
    • 5444228543 scopus 로고    scopus 로고
    • High-density lipoprotein subfractions and risk of coronary artery disease
    • Morgan J, Carey C, Lincoff A, et al. High-density lipoprotein subfractions and risk of coronary artery disease [J]. Curr Atheroscler Rep, 2004, 6: 359-365.
    • (2004) Curr Atheroscler Rep , vol.6 , pp. 359-365
    • Morgan, J.1    Carey, C.2    Lincoff, A.3
  • 9
    • 77957661914 scopus 로고    scopus 로고
    • Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
    • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25: 603-605.
    • (2010) Eur J Epidemiol , vol.25 , pp. 603-605
    • Stang, A.1
  • 10
    • 35248829949 scopus 로고    scopus 로고
    • Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome
    • Kuller L H, Grandits G, Cohen J D, et al. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome [J]. Atherosclerosis, 2007, 195: 122-128.
    • (2007) Atherosclerosis , vol.195 , pp. 122-128
    • Kuller, L.H.1    Grandits, G.2    Cohen, J.D.3
  • 11
    • 61849110301 scopus 로고    scopus 로고
    • Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
    • Mora S, Otvos J D, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women [J]. Circulation, 2009, 119: 931-939.
    • (2009) Circulation , vol.119 , pp. 931-939
    • Mora, S.1    Otvos, J.D.2    Rifai, N.3
  • 12
    • 58749094271 scopus 로고    scopus 로고
    • High-density lipoprotein particle size and concentration and coronary risk
    • El Harchaoui K, Arsenault B J, Franssen R, et al. High-density lipoprotein particle size and concentration and coronary risk [J]. Ann Intern Med, 2009, 150: 84-93.
    • (2009) Ann Intern Med , vol.150 , pp. 84-93
    • El Harchaoui, K.1    Arsenault, B.J.2    Franssen, R.3
  • 13
    • 70450186915 scopus 로고    scopus 로고
    • Lipoprotein particle subclasses, cardiovascular disease and HIV infection
    • Duprez D A, Kuller L H, Tracy R, et al. Lipoprotein particle subclasses, cardiovascular disease and HIV infection [J]. Atherosclerosis, 2009, 207: 524-529.
    • (2009) Atherosclerosis , vol.207 , pp. 524-529
    • Duprez, D.A.1    Kuller, L.H.2    Tracy, R.3
  • 14
    • 84864767131 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)
    • Mackey R H, Greenland P, Goff D C, et al. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) [J]. J Am Coll Cardiol, 2012, 60: 508-516.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 508-516
    • Mackey, R.H.1    Greenland, P.2    Goff, D.C.3
  • 15
    • 84859373468 scopus 로고    scopus 로고
    • Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
    • Berger J S, McGinn A P, Howard B V, et al. Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women[J]. Stroke, 2012, 43: 958-966.
    • (2012) Stroke , vol.43 , pp. 958-966
    • Berger, J.S.1    McGinn, A.P.2    Howard, B.V.3
  • 16
    • 0037099259 scopus 로고    scopus 로고
    • Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial
    • Rosenson R S, Otvos J D, Freedman D S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial[J]. Am J Cardiol, 2002, 90: 89-94.
    • (2002) Am J Cardiol , vol.90 , pp. 89-94
    • Rosenson, R.S.1    Otvos, J.D.2    Freedman, D.S.3
  • 17
    • 85027944383 scopus 로고    scopus 로고
    • Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study
    • Parish S, Offer A, Clarke R, et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study[J]. Circulation, 2012, 125: 2469-2478.
    • (2012) Circulation , vol.125 , pp. 2469-2478
    • Parish, S.1    Offer, A.2    Clarke, R.3
  • 18
    • 0038201868 scopus 로고    scopus 로고
    • Effects of extended-release niacin on lipoprotein subclass distribution
    • Morgan J M, Capuzzi D M, Baksh R I, et al. Effects of extended-release niacin on lipoprotein subclass distribution [J]. Am J Cardiol, 2003, 91: 1432-1436.
    • (2003) Am J Cardiol , vol.91 , pp. 1432-1436
    • Morgan, J.M.1    Capuzzi, D.M.2    Baksh, R.I.3
  • 19
    • 0036794693 scopus 로고    scopus 로고
    • Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
    • Asztalos B F, Horvath K V, McNamara J R, et al. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients[J]. J Lipid Res, 2002, 43: 1701-1707.
    • (2002) J Lipid Res , vol.43 , pp. 1701-1707
    • Asztalos, B.F.1    Horvath, K.V.2    McNamara, J.R.3
  • 20
    • 0038300497 scopus 로고    scopus 로고
    • Change in alphal HDL concentration predicts progression in coronary artery stenosis
    • Asztalos B F, Batista M, Horvath K V, et al. Change in alphal HDL concentration predicts progression in coronary artery stenosis [J]. Arterioscler Thromb Vasc Biol, 2003, 23: 847-852.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 847-852
    • Asztalos, B.F.1    Batista, M.2    Horvath, K.V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.